The effect of early treatment in children with chronic hepatitis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 37, Issue 3, 2003, Pages 252-257

  Hartman, Corina ^a   Berkowitz, Drora ^a   Rimon, Nurit ^b   Shamir, Raanan ^a  

^a MEYER CHILDREN S HOSPITAL   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Children; Chronic hepatitis C; Interferon; Ribavirin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; PARACETAMOL; REBETRON; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; VIRUS RNA; ANTIVIRUS AGENT;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ANEMIA; ANOREXIA; CHILD; CHILL; CHRONIC HEPATITIS; CLINICAL ARTICLE; EARLY DIAGNOSIS; FEMALE; FEVER; FLU LIKE SYNDROME; HEADACHE; HEPATITIS C; HUMAN; INSOMNIA; MALAISE; MALE; MYALGIA; NEUTROPENIA; PRIORITY JOURNAL; RESTLESSNESS; REVIEW; SIDE EFFECT; SUICIDAL BEHAVIOR; WEIGHT REDUCTION; ARTICLE; BLOOD; COHORT ANALYSIS; DRUG COMBINATION; FOLLOW UP; LIVER; PATHOLOGY; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; VIREMIA; VIROLOGY;

HEPATITIS C VIRUS;

ANTIVIRAL AGENTS; CHILD; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LIVER; MALE; RETROSPECTIVE STUDIES; RIBAVIRIN; RNA, VIRAL; TIME FACTORS; TREATMENT OUTCOME; VIREMIA;

EID: 1542472115     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200309000-00010     Document Type: Review

References (28)

1. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus in the United States, 1988 through 1994. N Engl J Med 1999;341:556-62.
2. Aach RD, Yomtovian RA, Hack M. Neonatal and pediatric posttransfusion hepatitis C: a look back and a look forward. Pediatrics 2000;105:836-42.
3. Bortolotti F, Iorio R, Resti M, et al. An epidemiological survey of hepatitis C virus infection in Italian children in the decade 1990-1999. J Pediatr Gastroenterol Nutr 2001;32:562-6.
4. Ruiz-Moreno M, Leal-Orozco A, Millan A. Hepatitis C virus infection in children. J Hepatol 1999;31(suppl 1):124-9.
5. Jacobson KR, Murray K, Zellos A, et al. An analysis of published trials of interferon monotherapy in children with chronic hepatitis C. J Pediatr Gatroenterol Nutr 2002;34:52-8.
6. Suoglu OD, Elkabes B, Sokucu S, et al. Does interferon and ribavirin combination therapy increase the rate of treatment response in children with chronic hepatitis C? J Pediatr Gastroenterol Nutr 2002;34:199-206.
7. Simmonds P, Holmes EC, Cha TA, et al. Classification of hepatitis C virus in six major genotypes and a series subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993;74:2391-9.
8. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
9. Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-20.
10. Seef LB, Buskell-Bales Z, Wright EC, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992;327:1906-11.
11. Locasciulli A, Gornati G, Tagger A, et al. Hepatitis C virus infection and chronic liver disease in children with leukemia in long-term remission. Blood 1991;78:1619-22.
12. Arico M, Maggiore G, Silini E, et al. Hepatitis C virus infection in children treated for acute lymphoblastic leukemia. Blood 1994;84:2919-22.
13. Cesaro S, Petris MG, Rossetti F, et al. Chronic hepatitis C virus infection after treatment for pediatric malignancy. Blood 1997;90:1315-20.
14. Locasciulli A, Testa M, Pontisso P, et al. Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. Blood 1997;90:4628-33.
15. Paul IM, Sanders J, Ruggiero F, et al. Chronic hepatitis C virus infection in leukemia survivors: prevalence, viral load and severity of liver disease. Blood 1999;93:1672-7.
16. Gordon SC, Bayati N, Silverman AL. Clinical outcome of hepatitis C as a function of mode of transmission. Hepatology 1998;28:562-7.
17. Vogt M, Lang T, Frosner G, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 1999;341:866-70.
18. Hoshiyama A, Kimura A, Fujisawa T, et al. Clinical and histologic features of chronic hepatitis C virus infection after blood transfusion in Japanese children. Pediatrics 2000;105:62-5.
19. Badizadegan K, Jonas MM, Ott MJ, et al. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology 1998;28:1416-23.
20. Stickland DK, Jenkins JJ, Hudson MM. Hepatitis C infection and hepatocellular carcinoma after treatment of childhood cancer. J Pediatr Hematol Oncol 2001;23:527-9.
21. Cesaro S, Bortolotti F, Petris MG, et al. Interferon treatment of chronic hepatitis C in patients cured of pediatric malignancies. Haematologica 2000;85:63-6.
22. Clemente MG, Congia M, Lai ME, et al. Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis C. J Pediatr 1994;125:123-8.
23. Ko JS, Choe YH, Kim EJ, et al. Interferon-alpha treatment of chronic hepatitis C in children with hemophilia. J Pediatr Gastroenterol Nutr 2001;32:41-4.
24. Christensson B, Wiebe T, Akesson A, Widell A. Interferon-alpha and ribavirin treatment of hepatitis C in children with malignancy in remission. Clin Infect Dis 2000;30:585-6.
25. Lackner H, Moser A, Deutsch J, et al. Interferon-alpha and ribavirin in treating children and young adults with chronic hepatitis C after malignancy. Pediatrics 2000;106:E53.
26. Suoglu OD, Elkabes B, Sokucu S, et al. Does interferon and ribavirin combination therapy increase the rate of treatment response in children with chronic hepatitis C? J Pediatr Gastroenterol Nutr 2002;34:199-206.
27. Chemello L, Cavaletto L, Bernardinello E, et al. The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C. J Hepatol 1995;23(suppl):8-12.
28. Jaeckel E, Cornberg M, Wedemeyer H, et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 2001;345:1452-7.